Definitive Healthcare Corp. (NASDAQ:DH) Shares Purchased by American International Group Inc.

American International Group Inc. increased its stake in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 4,964.6% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,727 shares of the company’s stock after purchasing an additional 21,298 shares during the quarter. American International Group Inc.’s holdings in Definitive Healthcare were worth $239,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Rhumbline Advisers boosted its position in shares of Definitive Healthcare by 3.3% during the 1st quarter. Rhumbline Advisers now owns 32,786 shares of the company’s stock worth $339,000 after acquiring an additional 1,055 shares in the last quarter. Public Employees Retirement System of Ohio boosted its position in shares of Definitive Healthcare by 6.8% during the 4th quarter. Public Employees Retirement System of Ohio now owns 17,546 shares of the company’s stock worth $193,000 after acquiring an additional 1,116 shares in the last quarter. PNC Financial Services Group Inc. boosted its position in shares of Definitive Healthcare by 34.6% during the 4th quarter. PNC Financial Services Group Inc. now owns 5,092 shares of the company’s stock worth $56,000 after acquiring an additional 1,309 shares in the last quarter. HighTower Advisors LLC boosted its position in shares of Definitive Healthcare by 11.3% during the 1st quarter. HighTower Advisors LLC now owns 13,251 shares of the company’s stock worth $109,000 after acquiring an additional 1,341 shares in the last quarter. Finally, Arizona State Retirement System boosted its position in shares of Definitive Healthcare by 13.4% during the 2nd quarter. Arizona State Retirement System now owns 12,089 shares of the company’s stock worth $133,000 after acquiring an additional 1,433 shares in the last quarter.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on DH shares. Bank of America lowered their price objective on Definitive Healthcare from $12.00 to $10.50 and set a “neutral” rating for the company in a research report on Tuesday, August 15th. Canaccord Genuity Group decreased their target price on Definitive Healthcare from $13.00 to $12.00 and set a “buy” rating for the company in a research report on Tuesday, August 15th. Robert W. Baird cut Definitive Healthcare from an “outperform” rating to a “neutral” rating and set a $13.00 target price for the company. in a research report on Monday, July 24th. Needham & Company LLC reissued a “buy” rating and issued a $15.00 target price on shares of Definitive Healthcare in a research report on Tuesday, August 15th. Finally, The Goldman Sachs Group decreased their target price on Definitive Healthcare from $17.00 to $10.50 and set a “neutral” rating for the company in a research report on Wednesday, August 16th. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $11.94.

Definitive Healthcare Stock Up 1.4 %

DH opened at $8.25 on Tuesday. The business has a 50 day moving average price of $7.35 and a two-hundred day moving average price of $9.30. The company has a quick ratio of 2.55, a current ratio of 2.55 and a debt-to-equity ratio of 0.20. The company has a market cap of $959.71 million, a PE ratio of -5.09, a P/E/G ratio of 5.21 and a beta of 0.84. Definitive Healthcare Corp. has a 52 week low of $5.53 and a 52 week high of $14.03.

Insider Buying and Selling at Definitive Healthcare

In other news, Director Sea Vii Management, Llc sold 6,656 shares of the stock in a transaction that occurred on Thursday, August 24th. The stock was sold at an average price of $9.39, for a total transaction of $62,499.84. Following the completion of the transaction, the director now directly owns 1,441,657 shares of the company’s stock, valued at approximately $13,537,159.23. The sale was disclosed in a document filed with the SEC, which is accessible through this link. 15.27% of the stock is owned by company insiders.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.